✦ LIBER ✦

Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer

✍ Scribed by Antonio Jimeno; Cristina Grávalos; Pilar Escudero; Isabel Sevilla; M. Eugenia Vega-Villegas; Vicente Alonso; Ignacio Juez; Rocío García-Carbonero; Humberto Bovio; Ramón Colomer; Hernán Cortés-Funes

Book ID: 107596312
Publisher: Springer Milan
Year: 2008
Tongue: Spanish
Weight: 127 KB
Volume: 10
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-008-0153-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of gefitinib, irinotecan,

Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer

✍ Jeffrey A. Meyerhardt; Jeffrey W. Clark; Jeffrey G. Supko; Joseph P. Eder; Shuji 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 329 KB

Mitomycin-C and capecitabine as third-li

Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study

✍ Do Hyoung Lim; Young Suk Park; Byeong-Bae Park; Sang Hoon Ji; Jeeyun Lee; Keon W 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB

Phase I and pharmacokinetic study of vat

Phase I and pharmacokinetic study of vatalanib plus capecitabine in patients with advanced cancer

✍ Richard L. Schilsky; David Geary; Linda Skoog; Apurva A. Desai; Joyce Valickas; 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 163 KB

Phase II study of capecitabine plus oxal

Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer

✍ Yu Hong Li; Hui Yan Luo; Feng Hua Wang; Zhi Qiang Wang; Miao Zhen Qiu; Yan Xia S 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 234 KB

Phase II study of tallysomycin S10b in p

Phase II study of tallysomycin S10b in patients with advanced colorectal cancer

✍ C. Nicaise; J. Ajani; P. Goudeau; M. Rozencweig; B. Levin; I. Krakoff 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 201 KB

A phase II study of irinotecan in combin

A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer

✍ Takeshi Kato; Hideyuki Mishima; Masakazu Ikenaga; Kouhei Murata; Hideyuki Ishida 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 259 KB